Corrections:
Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
Metrics: PDF 1653 views | ?
1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
2 Department of Pain Management, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research, Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
3 Department of Radiation Oncology, Peking University International Hospital, Beijing 102206, China
* These authors have contributed equally to this work
Published: August 03, 2018
This article has been corrected: The correct author affiliation is given below:
1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Original article: Oncotarget. 2016; 7:71341-71352. DOI: https://doi.org/10.18632/oncotarget.11217.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25958